Newsroom

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that Greg Ciongoli has been appointed to the Company's Board of Directors, effective September 16, 2026. Mr. Ciongoli will also serve as a member of the Audit Committee. Mr. C...

MAYODAN, N.C.--(BUSINESS WIRE)--Sturm, Ruger & Company, Inc. (NYSE: RGR) (“Ruger” or the “Company”) today announced that the applicable regulatory conditions under its previously announced Strategic Cooperation Agreement (“Agreement”) with Beretta Holding S.A. (“Beretta Holding”) have been satisfied. Therefore, consistent with the terms of the Agreement, the Company’s Board of Directors (the “Board”) has unanimously approved an amendment (the “Amendment”) to the Company’s shareholder rights...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on September 15, 2026, it granted stock options to purchase an aggregate of 53,175 shares of common stock to ni...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que le partenariat stratégique précédemment annoncé avec Sobi est désormais en vigueur, à la suite de l’expiration des délais d’attente applicables auprès des autorités de la concurrence et de la réalisation d’autres conditions. Comme annoncé le 10 août 2026, Innate Pharma a conclu un partenariat stratégique avec Sobi pour l’attribution...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the previously announced strategic partnership with Sobi is now effective following the expiration of applicable antitrust waiting periods and completion of other conditions. As announced on August 10, 2026, Innate Pharma entered a strategic partnership with Sobi to license lacutamab in T-cell lymphoma. Transaction closing triggers the USD 75...

NEW YORK--(BUSINESS WIRE)--Vishal Garg, founder and former CEO of Better Home & Finance Corporation (“Better” or the “Company”) (Nasdaq: BETR) and significant stockholder, today announced that leading independent proxy advisory firm, Egan-Jones Proxy Services (“Egan-Jones”), has recommended shareholders vote FOR both of the Garg Group’s proposals on the GREEN consent card, including the removal of five directors on Better’s Board of Directors (the “Board”). Mr. Garg commented: “We appreciat...

MOUNTAIN VIEW, Califórnia--(BUSINESS WIRE)--A Rubedo Life Sciences, Inc. (Rubedo) anunciou hoje um novo estudo clínico com o composto experimental RLS-1496 em pacientes com alopecia androgenética (AGA), com início previsto para outubro de 2026 e dados iniciais esperados para o primeiro semestre de 2027. O estudo marca a primeira avaliação clínica de um modulador de GPX4 para a perda de cabelo, ampliando o programa que estabeleceu o RLS-1496 como o primeiro modulador de GPX4 do mundo a entrar em...

سول، كوريا الجنوبية--(BUSINESS WIRE)--أعلنت Rebellions، الشركة الرائدة عالميًا في مجال البنية التحتية لاستدلال الذكاء الاصطناعي، وai&، شركة عالمية متكاملة رأسيًا في تقنيات الذكاء الاصطناعي، عن شراكة لنشر أنظمة RebelRack من Rebellions ضمن البنية التحتية المتنوعة لموارد الحوسبة لدى ai&، وذلك في إطار خدمة استدلال الذكاء الاصطناعي التي تقدمها الشركة في اليابان. وستتيح هذه الشراكة للشركات والمؤسسات الحكومية والمطورين إمكانية الوصول إلى خدمات استدلال مدعومة بتقنيات Rebellions ومنشورة داخل اليا...

DALLAS--(BUSINESS WIRE)--Bailey Brauer PLLC co-founder Alex Brauer has been named for a third consecutive year to the Lawdragon 500 Leading Real Estate Lawyers legal guide.Honored attorneys are leaders in the areas of Real Estate development, finance, leasing, REITs, construction, disputes and litigation. Their work, according to Lawdragon, “impacts everyone – from the offices we work in, to our homes, from affordable housing to the most swank Las Vegas resorts.”Mr. Brauer was honored for his ex...

MOUNTAIN VIEW, Californie--(BUSINESS WIRE)--Rubedo Life Sciences, Inc. (Rubedo) a annoncé aujourd’hui le lancement d’une nouvelle étude clinique sur le RLS-1496, un médicament expérimental, chez des patients atteints d’alopécie androgénétique (AGA), qui débutera en octobre 2026, les premières données étant attendues au cours du premier semestre 2027. Cette étude marque la toute première évaluation clinique d’un modulateur de GPX4 dans le traitement de la chute des cheveux, prolongeant ainsi le...